Shopping Cart

The shopping cart is empty

View courses and libraries and add them to the cart

{{item.title}} {{item.ceu}} hour {{item.ceu}} hours {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

{{item.title}} {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

Customers who Purchased
this Activity also Purchased

PREMIUM

{{recommendationsA.Title}}

Article
{{recommendationsA.Ceu}} hour | {{recommendationsA.Price | currency}} Article
{{recommendationsA.Ceu}} hours | {{recommendationsA.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsA.Type}} {{recommendationsA.Type}}

PREMIUM

{{recommendationsB.Title}}

Article
{{recommendationsB.Ceu}} hour | {{recommendationsB.Price | currency}} Article
{{recommendationsB.Ceu}} hours | {{recommendationsB.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsB.Type}} {{recommendationsB.Type}}

Total

{{totalCEUs}} hour{{totalCEUs}} hours

{{cart.total_amount | currency}}

@media (max-width: 991px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; } .site-header.fixed-top { position: relative; } .site-header .container-fluid { flex-flow: row wrap; } .nav-site-toggle { display: none; } .site-logo { position: static; top:auto; left:auto; transform: none; margin: 10px auto; order: 1; } .nav-site { width: 100%; position: static; overflow: visible; background-color: #ffffff; order: 3; } .nav-site-close { display: none; } .nav-site .nav-site-menu { width: 100%; height: auto; margin-left: 0; overflow: visible; } .nav-site .nav-item .dropdown-toggle::after{ display: none; } .nav-site .navbar-nav { margin: 0; padding: 0; position: relative; overflow: visible; overflow-y: visible; height: auto; } .nav-site .nav-breadcrumb { display: none; } .nav-site .nav-item .dropdown-toggle { background-color: #e1e1e1; text-transform: uppercase; } .nav-site .nav-item .dropdown-menu { position: static; margin: 0; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { font-weight: bold; background-color: #F2F4F6; } .nav-user { order: 2; margin: 0 10px 10px 10px; width: 100%; text-align: center; } .nav-user .user-menu { flex-flow: row wrap; } .nav-user .user-menu .user-menu-toggle { } .nav-user .user-menu .dropdown-menu { display: block; width: 100% !important; position: static; float: none; } .nav-user .user-menu .dropdown-menu::before, .nav-user .user-menu .dropdown-menu::after { display: none; } } @media (min-width: 992px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; margin-bottom: 500px; } .site-header.fixed-top { position: static; } .nav-site .nav-site-menu .navbar-nav .nav-item:hover > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item:focus-within > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.super { display: flex; flex-flow: row nowrap; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm1 { left: -376%; padding-right: 20px; width: 548px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:before { left: 80%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:after { left: 80.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 { left: 44%; padding-right: 20px; min-width: 6rem; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 .dropdown-item { min-width: 170px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:before { left: 5%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:after { left: 5.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { } .nav-user .user-menu .dropdown-menu { display: block; left: -20px; width: 210px !important; } .nav-user .user-menu .dropdown-menu .dropdown-item { min-width: 170px; } } .card-slider { overflow-x: auto; }

1. In the 2017 hypertension guideline, a recommended first-line antihypertensive agent is:

A. ACE inhibitor B. Hydralazine/isosorbide dinitrate C. b-blocker D. Loop diuretic

2. For adults with stage 1 hypertension and an ASCVD risk < 10%, the recommended blood pressure target is:

A. < 140/80 mmHg B. < 130/80 mmHg C. ? 130/85 mmHg D. < 120/85 mmHg

3. Per the ACCF/AHA guidelines, which of the following agents may be useful to decrease hospitalizations in patients who have stage C HFrEF?

A. Hydralazine/isosorbide dinitrate B. ACE inhibitors C. b-blocker D. Digoxin

4. What are common adverse events of hydralazine/isosorbide dinitrate therapy?

A. Headache, dizziness, and gastrointestinal effects B. Fluid retention, urinary tract infection, and dry mouth C. Tachycardia, angina, and nausea D. Dementia, hypotension, and thrombocytopenia

5. All of the following are appropriate dosage regimens for VTE prevention in acutely ill medical patients EXCEPT:

A. Enoxaparin 40 mg SC once daily B. Fondaparinux 2.5 mg SC once daily C. Dalteparin 2500 units SC once daily D. Unfractionated heparin 5000 units SC three times daily

6. A 45-year-old person with diabetes and a LDL level of 150 mg/dL attends your clinic for initial management of hyperlipidemia. As initial therapy, you appropriately recommend:

A. Atorvastatin 40 mg B. Simvastatin 80 mg C. Pravastatin 40 mg D. Pitavastatin 2 mg

7. When should a reduction in a statin dosage regimen be considered per the 2013 NCEP guidelines?

A. Once target LDL goal is achieved B. For patients on hemodialysis C. For patients with NYHA class II to IV HF D. If 2 consecutive LDL levels are < 40 mg/dL

8. The 2 most common signs/symptoms of PAD are:

A. Hypertension and pain at rest in the lower extremities B. Pain at rest in the lower extremities and intermittent claudication C. Hyperlipidemia and intermittent claudication D. Thickened toe nails and pain at rest in the lower extremities

9. How often should thyroid function be monitored during amiodarone therapy?

A. At baseline and every 12 months thereafter B. At baseline and every 3 to 6 months thereafter C. At baseline and every 6 months thereafter D. At each clinic visit

10. Which of the following is an appropriate recommendation for secondary prevention of cardioembolic ischemic stroke?

A. Aspirin 325 mg daily B. Clopidogrel 75 mg daily C. Dabigatran 150 mg daily D. Warfarin adjusted to an INR = 2.5

Evaluation Questions

11. To what extent did the program meet objective #1?

A. Excellent B. Very Good C. Good D. Fair E. Poor

12. To what extent did the program meet objective #2?

A. Excellent B. Very Good C. Good D. Fair E. Poor

13. To what extent did the program meet objective #3?

A. Excellent B. Very Good C. Good D. Fair E. Poor

14. To what extent did the program meet objective #4?

A. Excellent B. Very Good C. Good D. Fair E. Poor

15. Rate the effectiveness of how well the program related to your educational needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

A. Excellent B. Very Good C. Good D. Fair E. Poor

17. Rate the quality of the faculty:

A. Excellent B. Very Good C. Good D. Fair E. Poor

18. Rate the effectiveness and the overall usefulness of the material presented:

A. Excellent B. Very Good C. Good D. Fair E. Poor

19. Rate the appropriateness of the examination for this activity:

A. Excellent B. Very Good C. Good D. Fair E. Poor

20. Rate the effectiveness of how well the activity related to your practice needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

21. Rate the effectiveness of how well the activity will help you improve patient care:

A. Excellent B. Very Good C. Good D. Fair E. Poor

22. Will the information presented cause you to change your practice?

A. Yes B. No

23. Are you committed to making these changes?

A. Yes B. No

24. As a result of this activity, did you learn something new?

A. Yes B. No

25. What is your practice setting or area of practice?

A. Community Pharmacy/Independent B. Community Pharmacy/Chain C. Hospital/Health Systems D. Administrative/Pharmacy Director E. Critical Care Pharmacy F. Long-term Care G. Managed Care/PBM H. Oncology I. Specialty Pharmacy J. Industry/Manufacturing

26. How many years have you been in practice?

A. <5 B. 5 – 10 C. 11 – 20 D. >20

« Return to Activity